Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again
      1. Home/
      2. Media Center/
      3. Press releases /
      4. Research

      Research

      Research
      August 29, 2014

      Janssen Expands EXPLORER Global Cardiovascular Research Program to Evaluate the Role of XARELTO® in Addressing Critical Medical Needs

      New Studies Grow XARELTO® Clinical Development Program to More Than 275,000 Patients
      Learn more
      Research
      August 26, 2014

      Janssen Diagnostics Expands Research Portfolio to Include Next-Generation Sequencing

      Enhanced Offering to Enable ‘Dynamic Monitoring’ in Cancer Research
      Learn more
      Corporate
      June 19, 2014

      Johnson & Johnson Innovation Catalyzes New and Exciting Science and Technology in Pharmaceutical, Medical Device, Diagnostic and Consumer Healthcare Spaces

      Deals span new approaches for cancer, diabetes, autoimmune disease and Alzheimer’s, exciting technologies such as 3-D printing for trauma use, sedation monitoring, cardiac remodeling, probiotics for skin infections
      Learn more
      Research
      May 14, 2014

      Janssen Labs Expanding and Accelerating Coast to Coast -- Unveils Plan to Enhance the Innovation Ecosystem with New Incubator in South San Francisco and Awards One Year of Lab Space to Three Innovative Healthcare Companies in Boston

      Learn more
      Research
      March 31, 2014

      Janssen Expands the EXPLORER Global Cardiovascular Research Program with Three New Studies Evaluating XARELTO® in Patients at Risk for Venous Thromboembolism

      Learn more
      Research
      September 25, 2013

      Janssen R&D Ireland Announces Agreement with PATH for Early Development of Rilpivirine in Long-Acting Formulation for Potential Prophylactic Intervention

      Learn more
      Research
      July 10, 2013

      Johnson & Johnson Innovation Announces Finalists of Cognition Challenge

      $100,000 awarded for solutions addressing Alzheimer’s disease and cognitive disorders
      Learn more
      Research
      March 13, 2013

      Janssen Launches EXPLORER, Global Cardiovascular Research Program, Beginning with Five New Studies in Patients with Unmet Medical Needs

      Program Further Extends XARELTO® as the Most Studied New Oral Anticoagulant in the World Today
      Learn more
      Research
      December 12, 2012

      Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin/Metformin Fixed-Dose Combination Therapy to Treat Patients with Type 2 Diabetes

      Learn more
      Load more